- £520.38m
- £587.08m
- £316.30m
- 86
- 26
- 74
- 69
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 974 | 897 | 302 | 338 | 316 |
Cost of Revenue | |||||
Gross Profit | 568 | 519 | 214 | 236 | 228 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 894 | 885 | 294 | 349 | 305 |
Operating Profit | 80 | 11.6 | 7.7 | -11.3 | 10.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 65.5 | -4.1 | -7.1 | -29.1 | 8.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.2 | -1.5 | -4.9 | -31.1 | 5.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 38.4 | -3.3 | 26.9 | -188 | 5.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 38.4 | -3.3 | 26.9 | -188 | 5.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.032 | 0.129 | 0.011 | -0.021 | 0.076 |
Dividends per Share | |||||
Special Dividends per Share |